The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia by Monika Conchon

Get full text

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs by Monika Conchon

Get full text

Os inibidores de tirosino quinase de segunda geração The inhibitors of tyrosine kinase by Márcia T. Delamain, Mônika Conchon

Get full text

Dasatinib: clinical trials and management of adverse events in imatinib resistant/intolerant chronic myeloid leukemia by Monika Conchon, Carla Maria Boquimpani de Moura Freitas, Maria Aparecida do Carmo Rego, José Wilson Ramos Braga Junior

Get full text

Efficacy and Tolerability after Unusually Low Doses of Dasatinib in Chronic Myeloid Leukemia Patients Intolerant to Standard-Dose Dasatinib Therapy by Mariana Serpa, Sabri S. Sanabani, Israel Bendit, Fernanda Seguro, Flávia Xavier, Cláudia Bitti Barroso, Monika Conchon, Pedro Enrique Dorlhiac-Llacer

Get full text

Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012 by Carmino Antonio de Souza, Katia Borgia Barbosa Pagnano, Israel Bendit, Monika Conchon, Carla Maria Boquimpani de Moura Freitas, Arthur Moellmann Coelho, Vaneuza Araújo Moreira Funke, Wanderley Marques Bernardo

Get full text

Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and mo... by Fernanda Salles Seguro, Carolina Maria Pinto Domingues Carvalho Silva, Carla Maria Boquimpani de Moura, Monika Conchon, Laura Fogliatto, Vaneuza Araujo Moreira Funke, André Abdo, Ariane Vieira Scarlatelli Macedo, Marilia Harumi Higushi dos Santos, José Francisco Kerr Saraiva

Get full text